<?xml version="1.0" encoding="us-ascii"?><InstanceReport xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><Version>2.4.0.8</Version><ReportLongName>00000009 - Disclosure - 4. Asset Purchase Acquisitions</ReportLongName><DisplayLabelColumn>true</DisplayLabelColumn><ShowElementNames>false</ShowElementNames><RoundingOption /><HasEmbeddedReports>false</HasEmbeddedReports><Columns><Column FlagID="0"><Id>1</Id><IsAbstractGroupTitle>false</IsAbstractGroupTitle><LabelSeparator>

</LabelSeparator><CurrencyCode /><FootnoteIndexer /><hasSegments>false</hasSegments><hasScenarios>false</hasScenarios><MCU><KeyName /><CurrencySymbol /><contextRef><ContextID>from-2013-01-01-to-2013-06-30.12129.0.0.0.0.0.0.0</ContextID><EntitySchema>http://www.sec.gov/CIK</EntitySchema><EntityValue>0001335239</EntityValue><PeriodDisplayName /><PeriodType>duration</PeriodType><PeriodStartDate>2013-01-01T00:00:00</PeriodStartDate><PeriodEndDate>2013-06-30T00:00:00</PeriodEndDate><Segments /><Scenarios /></contextRef><UPS /><CurrencyCode /><OriginalCurrencyCode /></MCU><CurrencySymbol /><Labels><Label Key="CalendarSupplement" Id="0" Label="6 Months Ended" /><Label Key="Calendar" Id="1" Label="Jun. 30, 2013" /></Labels></Column></Columns><Rows><Row FlagID="0"><Id>1</Id><IsAbstractGroupTitle>true</IsAbstractGroupTitle><LabelSeparator>

</LabelSeparator><Level>1</Level><ElementName>us-gaap_BusinessCombinationsAbstract</ElementName><ElementPrefix>us-gaap_</ElementPrefix><IsBaseElement>true</IsBaseElement><BalanceType>na</BalanceType><PeriodType>duration</PeriodType><IsReportTitle>false</IsReportTitle><IsSegmentTitle>false</IsSegmentTitle><IsCalendarTitle>false</IsCalendarTitle><IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow><IsEquityAdjustmentRow>false</IsEquityAdjustmentRow><IsBeginningBalance>false</IsBeginningBalance><IsEndingBalance>false</IsEndingBalance><IsReverseSign>false</IsReverseSign><FootnoteIndexer /><Cells><Cell FlagID="0" ContextID="" UnitID=""><Id>1</Id><IsNumeric>false</IsNumeric><IsRatio>false</IsRatio><DisplayZeroAsNone>false</DisplayZeroAsNone><NumericAmount>0</NumericAmount><RoundedNumericAmount>0</RoundedNumericAmount><NonNumbericText /><FootnoteIndexer /><CurrencyCode /><CurrencySymbol /><IsIndependantCurrency>false</IsIndependantCurrency><ShowCurrencySymbol>false</ShowCurrencySymbol><DisplayDateInUSFormat>false</DisplayDateInUSFormat></Cell></Cells><ElementDataType>xbrli:stringItemType</ElementDataType><SimpleDataType>string</SimpleDataType><IsTotalLabel>false</IsTotalLabel><UnitID>0</UnitID><Label>Business Combinations [Abstract]</Label></Row><Row FlagID="0"><Id>2</Id><IsAbstractGroupTitle>false</IsAbstractGroupTitle><LabelSeparator>

</LabelSeparator><Level>2</Level><ElementName>us-gaap_BusinessCombinationDisclosureTextBlock</ElementName><ElementPrefix>us-gaap_</ElementPrefix><IsBaseElement>true</IsBaseElement><BalanceType>na</BalanceType><PeriodType>duration</PeriodType><IsReportTitle>false</IsReportTitle><IsSegmentTitle>false</IsSegmentTitle><IsCalendarTitle>false</IsCalendarTitle><IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow><IsEquityAdjustmentRow>false</IsEquityAdjustmentRow><IsBeginningBalance>false</IsBeginningBalance><IsEndingBalance>false</IsEndingBalance><IsReverseSign>false</IsReverseSign><FootnoteIndexer /><Cells><Cell FlagID="0" ContextID="from-2013-01-01-to-2013-06-30.12129.0.0.0.0.0.0.0" UnitID=""><Id>1</Id><IsNumeric>false</IsNumeric><IsRatio>false</IsRatio><DisplayZeroAsNone>false</DisplayZeroAsNone><NumericAmount>0</NumericAmount><RoundedNumericAmount>0</RoundedNumericAmount><NonNumbericText>&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 4 &amp;#150; Asset Purchase Acquisitions&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;

&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Asset Purchase Acquisition &amp;#150; MS Health,
Inc., March 28, 2012&lt;/u&gt;&lt;/p&gt;

&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On March 28, 2012, we, through a newly-formed
wholly-owned Illinois subsidiary, MS Health, Inc. (&amp;#147;MS Health&amp;#148;), closed on an Asset Purchase Agreement (&amp;#147;APA&amp;#148;)
with MS Health Software Corporation, a New Jersey corporation (&amp;#147;MSHSC&amp;#148;). Pursuant to the APA, we purchased all of MSHSC&amp;#146;s
assets, including all of its intellectual property, its business trademarks and copyrights, furniture, fixtures, equipment and
software in consideration for an aggregate of $500,000, of which $39,200 was paid in cash at the closing, $360,800 was financed
using a small business loan and $100,000 was paid by way of a Promissory Note (the &amp;#147;MSHSC Note&amp;#148;). The terms of the
MSHSC Note include interest at 6% per annum, a ten (10) year amortization, a right of offset, no payments of either principal or
interest for two (2) years and equal payments of principal and interest commencing in year 3, no prepayment penalty, and full payment
of all amounts due after five (5) years. The MSHSC Note is secured by a security interest over the assets of MS Health. We did
not purchase and MSHSC agreed to retain and be responsible for any and all liabilities of MSHSC. The acquisition was financed in
part with a $360,800 Small Business Administration (&amp;#147;SBA&amp;#148;) loan, bearing interest at fixed and variable rates. The
initial interest rate is 5.5% per year for three (3) years, consisting of the Prime Rate in effect on the first business day of
the month in which the SBA loan application was received, plus 2.25%. The loan terms then transition to a variable interest rate
over the remaining seven (7) years of the ten (10) year maturity term, calculated at 2.25% above the Prime Rate, as adjusted quarterly.
The Company must pay principal and interest payments of $3,916 monthly. The SBA Loan is guaranteed by PRMI, K9 Bytes, Desk Flex,
Inc., MS Health and the Company, and secured by the assets of MS Health and the Company.&lt;/p&gt;

&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;

&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;MSHSC developed and sells CHMCi, an enterprise
wide solution that includes tools to effectively provide, manage, bill, and track behavioral healthcare and social services. With
CMHCi, an organization will realize the benefits of increased efficiency, accountability, and productivity. CMHCi offers server-based,
internet, and secure cloud computing enabling the user to access information as required. By maintaining a complete electronic
client record, including data collection and reporting across multiple programs, locations, episodes of care, and service providers,
CMHCi helps eliminate redundant record keeping. The scheduler component tracks client, staff, and group appointments. Easy to use,
it interfaces seamlessly with service authorization tracking, service history, and billing. The integrated financial reporting
component provides the basis for an efficient and comprehensive accounting system, including electronic claims and remittance,
third party insurance, and client, municipality, and grantor billing.&lt;/p&gt;

&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;

&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In connection with the Asset Purchase, the shareholders
of MSHSC and the Company (through MS Health) entered into a Covenant Not to Compete; Consulting Agreement, Non-Competition and
Consulting Agreement, pursuant to which the shareholders of MSHSC agreed to provide consulting services to the Company for a period
of six months following closing. Pursuant to the agreement, the shareholders of MSHSC agreed not to compete against the Company
for two years from the closing of the acquisition.&lt;/p&gt;

&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;

&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;This acquisition was
accounted for as a business combination under the purchase method of accounting, given that substantially all of the Company&amp;#146;s
assets and ongoing operations were acquired. The purchase resulted in $114,627 of goodwill. According to the purchase method of
accounting, the Company recognized the identifiable assets acquired and liabilities assumed as follows:&lt;/p&gt;

&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;

&lt;table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-top: 3pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="padding-top: 3pt"&gt;&amp;#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-top: 3pt; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;March 28,&lt;/font&gt;&lt;/td&gt;
    &lt;td style="padding-top: 3pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-top: 3pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="padding-top: 3pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;2012&lt;/font&gt;&lt;/td&gt;
    &lt;td style="padding-top: 3pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCFFCC"&gt;
    &lt;td style="padding-top: 3pt; text-align: justify"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Consideration:&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
    &lt;td style="padding-top: 3pt"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="padding-top: 3pt"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="padding-top: 3pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="padding-top: 3pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="width: 84%; padding-top: 3pt; text-align: justify"&gt;&lt;font style="font-size: 8pt"&gt;Cash paid at closing&lt;/font&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-top: 3pt"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="width: 1%; padding-top: 3pt"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;
    &lt;td style="width: 13%; padding-top: 3pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;39,200&lt;/font&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-top: 3pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCFFCC"&gt;
    &lt;td style="padding-top: 3pt; text-align: justify"&gt;&lt;font style="font-size: 8pt"&gt;Small business loan&lt;sup&gt;(1)&lt;/sup&gt;&lt;/font&gt;&lt;/td&gt;
    &lt;td style="padding-top: 3pt"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="padding-top: 3pt"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="padding-top: 3pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;360,800&lt;/font&gt;&lt;/td&gt;
    &lt;td style="padding-top: 3pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-top: 3pt; padding-bottom: 1pt; text-align: justify"&gt;&lt;font style="font-size: 8pt"&gt;Seller financed note payable&lt;sup&gt;(2)(3)&lt;/sup&gt;&lt;/font&gt;&lt;/td&gt;
    &lt;td style="padding-top: 3pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-top: 3pt"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-top: 3pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;124,697&lt;/font&gt;&lt;/td&gt;
    &lt;td style="padding-top: 3pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCFFCC"&gt;
    &lt;td style="padding-top: 3pt; padding-bottom: 2.5pt; text-align: justify; text-indent: 22.95pt"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Fair value of total consideration exchanged&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
    &lt;td style="padding-top: 3pt; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double; padding-top: 3pt"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double; padding-top: 3pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;524,697&lt;/font&gt;&lt;/td&gt;
    &lt;td style="padding-top: 3pt; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-top: 3pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="padding-top: 3pt"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="padding-top: 3pt"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="padding-top: 3pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="padding-top: 3pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCFFCC"&gt;
    &lt;td style="padding-top: 3pt; text-align: justify"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Fair value of identifiable assets acquired assumed:&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
    &lt;td style="padding-top: 3pt"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="padding-top: 3pt"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="padding-top: 3pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="padding-top: 3pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-top: 3pt; text-align: justify"&gt;&lt;font style="font-size: 8pt"&gt;Other current assets&lt;/font&gt;&lt;/td&gt;
    &lt;td style="padding-top: 3pt"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="padding-top: 3pt"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;
    &lt;td style="padding-top: 3pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;7,367&lt;/font&gt;&lt;/td&gt;
    &lt;td style="padding-top: 3pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCFFCC"&gt;
    &lt;td style="padding-top: 3pt; text-align: justify"&gt;&lt;font style="font-size: 8pt"&gt;Equipment&lt;/font&gt;&lt;/td&gt;
    &lt;td style="padding-top: 3pt"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="padding-top: 3pt"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="padding-top: 3pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2,703&lt;/font&gt;&lt;/td&gt;
    &lt;td style="padding-top: 3pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-top: 3pt; text-align: justify"&gt;&lt;font style="font-size: 8pt"&gt;Contracts&lt;/font&gt;&lt;/td&gt;
    &lt;td style="padding-top: 3pt"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="padding-top: 3pt"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="padding-top: 3pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;258,000&lt;/font&gt;&lt;/td&gt;
    &lt;td style="padding-top: 3pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCFFCC"&gt;
    &lt;td style="padding-top: 3pt; text-align: justify"&gt;&lt;font style="font-size: 8pt"&gt;Technology-based intangible assets&lt;/font&gt;&lt;/td&gt;
    &lt;td style="padding-top: 3pt"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="padding-top: 3pt"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="padding-top: 3pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;124,000&lt;/font&gt;&lt;/td&gt;
    &lt;td style="padding-top: 3pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-top: 3pt; padding-bottom: 1pt; text-align: justify"&gt;&lt;font style="font-size: 8pt"&gt;Non-compete agreement&lt;/font&gt;&lt;/td&gt;
    &lt;td style="padding-top: 3pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-top: 3pt"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-top: 3pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;18,000&lt;/font&gt;&lt;/td&gt;
    &lt;td style="padding-top: 3pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCFFCC"&gt;
    &lt;td style="padding-top: 3pt; padding-bottom: 1pt; text-align: justify; text-indent: 13.05pt"&gt;&lt;font style="font-size: 8pt"&gt;Total fair value of assets assumed&lt;/font&gt;&lt;/td&gt;
    &lt;td style="padding-top: 3pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-top: 3pt"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-top: 3pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;410,070&lt;/font&gt;&lt;/td&gt;
    &lt;td style="padding-top: 3pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-top: 3pt; padding-bottom: 2.5pt; text-align: justify"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Consideration paid in excess of fair value (Goodwill)&lt;sup&gt;(4)&lt;/sup&gt;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
    &lt;td style="padding-top: 3pt; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double; padding-top: 3pt"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double; padding-top: 3pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;114,627&lt;/font&gt;&lt;/td&gt;
    &lt;td style="padding-top: 3pt; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 8pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0; margin-bottom: 0; margin-left: 0"&gt;&lt;b&gt;&lt;sup&gt;&amp;#160;&lt;/sup&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 8pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0; margin-bottom: 0; margin-left: 0"&gt;&lt;b&gt;&lt;sup&gt;(1)&lt;/sup&gt;&lt;/b&gt;
Consideration included partial proceeds obtained from a $360,800 Small Business Association (&amp;#147;SBA&amp;#148;) loan, bearing interest
at fixed and variable rates. The initial interest rate is 5.5% per year for three (3) years, consisting of the Prime Rate in effect
on the first business day of the month in which the SBA loan application was received, plus 2.25%. The loan terms then transition
to a variable interest rate over the remaining seven (7) years of the ten (10) year maturity term, calculated at 2.25% above the
Prime Rate, as adjusted quarterly. The Company must pay principal and interest payments of $3,916 monthly. The SBA Loan is guaranteed
by PRMI, K9 Bytes, Desk Flex, Inc., MS Health and the Company, and secured by the assets of MS Health and the Company.&lt;/p&gt;

&lt;p style="font: 8pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0; margin-bottom: 0; margin-left: 0"&gt;&lt;b&gt;&lt;sup&gt;(2)&lt;/sup&gt;&lt;/b&gt;
Consideration included an unsecured $100,000 seller financed note payable (&amp;#147;MSHSC Note&amp;#148;), bearing interest at 6% per
annum, a ten (10) year amortization, a right of offset, no payments of either principal or interest for two (2) years and equal
payments of principal and interest commencing in year 3, no prepayment penalty, and full payment of all amounts due after five
(5) years. The MSHSC Note is secured by a security interest over the assets of MS Health. We did not purchase and MSHSC agreed
to retain and be responsible for any and all liabilities of MSHSC.&lt;/p&gt;

&lt;p style="font: 8pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0; margin-bottom: 0; margin-left: 0"&gt;&lt;b&gt;&lt;sup&gt;(3)&lt;/sup&gt;&lt;/b&gt;
The fair value of the seller financed note in excess of the $100,000 principal balance attributable to the deferred payment terms
will be amortized to interest expense over the deferred financing period.&lt;/p&gt;

&lt;p style="font: 8pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0; margin-bottom: 0; margin-left: 0"&gt;&lt;b&gt;&lt;sup&gt;(4)&lt;/sup&gt;&lt;/b&gt;
The consideration paid in excess of the net fair value of assets acquired and liabilities assumed has been recognized as goodwill.&lt;/p&gt;

&lt;p style="font: 8pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0; margin-bottom: 0; margin-left: 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;

&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Management believes the product line of MS Health,
customer base and other assets acquired will enable the Company to enhance their business model and strengthen its future cash
flows to fund operations and take advantage of additional growth opportunities.&lt;/p&gt;

&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;

&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The unaudited supplemental pro forma results
of operations of the combined entities had the dates of the acquisitions been January 1, 2013 or January 1, 2012 are as follows:&lt;/p&gt;

&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&amp;#160;&lt;/p&gt;

&lt;table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify; text-indent: -10pt"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Combined Pro Forma:&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify; text-indent: -10pt"&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td colspan="6"&gt;
        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;For the six months ended&lt;/p&gt;
        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;June 30,&lt;/p&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify; text-indent: -10pt"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;2013&lt;/font&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;2012&lt;/font&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCFFCC"&gt;
    &lt;td style="width: 68%; padding-left: 10pt; text-align: justify; text-indent: -10pt"&gt;&lt;font style="font-size: 8pt"&gt;Revenue:&lt;/font&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;
    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;487,129&lt;/font&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;
    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;720,390&lt;/font&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify; text-indent: -10pt"&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCFFCC"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify; text-indent: -10pt"&gt;&lt;font style="font-size: 8pt"&gt;Expenses:&lt;/font&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 20pt; text-align: justify; text-indent: -10pt"&gt;&lt;font style="font-size: 8pt"&gt;Operating expenses&lt;/font&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2,194,288&lt;/font&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,130,649&lt;/font&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCFFCC"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify; text-indent: -10pt"&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify; text-indent: -10pt"&gt;&lt;font style="font-size: 8pt"&gt;Net operating income (loss)&lt;/font&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(1,707,159&lt;/font&gt;&lt;/td&gt;
    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(410,259&lt;/font&gt;&lt;/td&gt;
    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCFFCC"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify; text-indent: -10pt"&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 20pt; text-align: justify; text-indent: -10pt"&gt;&lt;font style="font-size: 8pt"&gt;Other income (expense)&lt;/font&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(358,990&lt;/font&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(87,396&lt;/font&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCFFCC"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify; text-indent: -10pt"&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 10pt; text-align: justify; text-indent: -10pt"&gt;&lt;font style="font-size: 8pt"&gt;Net income (loss)&lt;/font&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(2,066,149&lt;/font&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(497,655&lt;/font&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCFFCC"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify; text-indent: -10pt"&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify; text-indent: -10pt"&gt;&lt;font style="font-size: 8pt"&gt;Weighted average number of common shares&lt;/font&gt;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCFFCC"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 20pt; text-align: justify; text-indent: -10pt"&gt;&lt;font style="font-size: 8pt"&gt;Outstanding &amp;#150; basic and fully diluted&lt;/font&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,283,603,738&lt;/font&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;31,586,526&lt;/font&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 10pt; text-align: justify; text-indent: -10pt"&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;
    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCFFCC"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 10pt; text-align: justify; text-indent: -10pt"&gt;&lt;font style="font-size: 8pt"&gt;Net income (loss) per share &amp;#150; basic and fully diluted&lt;/font&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(0.00&lt;/font&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(0.02&lt;/font&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</NonNumbericText><FootnoteIndexer /><CurrencyCode /><CurrencySymbol /><IsIndependantCurrency>false</IsIndependantCurrency><ShowCurrencySymbol>false</ShowCurrencySymbol><DisplayDateInUSFormat>false</DisplayDateInUSFormat></Cell></Cells><ElementDataType>nonnum:textBlockItemType</ElementDataType><SimpleDataType>na</SimpleDataType><ElementDefenition>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</ElementDefenition><ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef

 -Publisher FASB

 -Name Accounting Standards Codification

 -Topic 805

 -SubTopic 30

 -Section 50

 -Paragraph 2

 -URI http://asc.fasb.org/extlink&amp;oid=7488404&amp;loc=d3e6996-128479



Reference 2: http://www.xbrl.org/2003/role/presentationRef

 -Publisher FASB

 -Name Accounting Standards Codification

 -Topic 805

 -SubTopic 30

 -Section 50

 -Paragraph 3

 -URI http://asc.fasb.org/extlink&amp;oid=7488404&amp;loc=d3e7000-128479



Reference 3: http://www.xbrl.org/2003/role/presentationRef

 -Publisher FASB

 -Name Accounting Standards Codification

 -Topic 805

 -SubTopic 20

 -Section 50

 -Paragraph 2

 -URI http://asc.fasb.org/extlink&amp;oid=6910749&amp;loc=d3e4922-128472



Reference 4: http://www.xbrl.org/2003/role/presentationRef

 -Publisher FASB

 -Name Accounting Standards Codification

 -Topic 805

 -SubTopic 20

 -Section 50

 -Paragraph 3

 -URI http://asc.fasb.org/extlink&amp;oid=6910749&amp;loc=d3e4926-128472



Reference 5: http://www.xbrl.org/2003/role/presentationRef

 -Publisher FASB

 -Name Accounting Standards Codification

 -Topic 805

 -SubTopic 20

 -Section 50

 -Paragraph 4

 -URI http://asc.fasb.org/extlink&amp;oid=6910749&amp;loc=d3e4934-128472



Reference 6: http://www.xbrl.org/2003/role/presentationRef

 -Publisher FASB

 -Name Accounting Standards Codification

 -Topic 805

 -SubTopic 10

 -Section 50

 -Paragraph 1

 -URI http://asc.fasb.org/extlink&amp;oid=25497992&amp;loc=d3e1383-128463



Reference 7: http://www.xbrl.org/2003/role/presentationRef

 -Publisher FASB

 -Name Accounting Standards Codification

 -Topic 805

 -SubTopic 10

 -Section 50

 -Paragraph 2

 -URI http://asc.fasb.org/extlink&amp;oid=25497992&amp;loc=d3e1392-128463



Reference 8: http://www.xbrl.org/2003/role/presentationRef

 -Publisher FASB

 -Name Accounting Standards Codification

 -Topic 805

 -SubTopic 10

 -Section 50

 -Paragraph 3

 -URI http://asc.fasb.org/extlink&amp;oid=25497992&amp;loc=d3e1486-128463



Reference 9: http://www.xbrl.org/2003/role/presentationRef

 -Publisher FASB

 -Name Accounting Standards Codification

 -Topic 805

 -SubTopic 30

 -Section 50

 -Paragraph 1

 -URI http://asc.fasb.org/extlink&amp;oid=7488404&amp;loc=d3e6927-128479



Reference 10: http://www.xbrl.org/2003/role/presentationRef

 -Publisher FASB

 -Name Accounting Standards Codification

 -Topic 805

 -SubTopic 10

 -Section 50

 -Paragraph 5

 -URI http://asc.fasb.org/extlink&amp;oid=25497992&amp;loc=d3e1497-128463



Reference 11: http://www.xbrl.org/2003/role/presentationRef

 -Publisher FASB

 -Name Accounting Standards Codification

 -Topic 805

 -SubTopic 10

 -Section 50

 -Paragraph 4

 -URI http://asc.fasb.org/extlink&amp;oid=25497992&amp;loc=d3e1490-128463



Reference 12: http://www.xbrl.org/2003/role/presentationRef

 -Publisher FASB

 -Name Accounting Standards Codification

 -Topic 805

 -SubTopic 30

 -Section 50

 -Paragraph 4

 -URI http://asc.fasb.org/extlink&amp;oid=7488404&amp;loc=d3e7008-128479



Reference 13: http://www.xbrl.org/2003/role/presentationRef

 -Publisher FASB

 -Name Accounting Standards Codification

 -Topic 805

 -SubTopic 20

 -Section 50

 -Paragraph 1

 -URI http://asc.fasb.org/extlink&amp;oid=6910749&amp;loc=d3e4845-128472



Reference 14: http://www.xbrl.org/2003/role/presentationRef

 -Publisher FASB

 -Name Accounting Standards Codification

 -Topic 805

 -SubTopic 10

 -Section 50

 -Paragraph 6

 -URI http://asc.fasb.org/extlink&amp;oid=25497992&amp;loc=d3e1500-128463



Reference 15: http://www.xbrl.org/2003/role/presentationRef

 -Publisher FASB

 -Name Accounting Standards Codification

 -Topic 805

 -SubTopic 10

 -Section 50

 -Paragraph 7

 -URI http://asc.fasb.org/extlink&amp;oid=25497992&amp;loc=d3e1524-128463



</ElementReferences><IsTotalLabel>false</IsTotalLabel><UnitID>0</UnitID><Label>Asset Purchase Acquisitions</Label></Row></Rows><Footnotes /><IsEquityReport>false</IsEquityReport><ReportName>4. Asset Purchase Acquisitions</ReportName><MonetaryRoundingLevel>UnKnown</MonetaryRoundingLevel><SharesRoundingLevel>UnKnown</SharesRoundingLevel><PerShareRoundingLevel>UnKnown</PerShareRoundingLevel><ExchangeRateRoundingLevel>UnKnown</ExchangeRateRoundingLevel><HasCustomUnits>true</HasCustomUnits><IsEmbedReport>false</IsEmbedReport><IsMultiCurrency>false</IsMultiCurrency><ReportType>Sheet</ReportType><RoleURI>http://epazz.com/role/AssetPurchaseAcquisitions</RoleURI><NumberOfCols>1</NumberOfCols><NumberOfRows>2</NumberOfRows></InstanceReport>
